Literature DB >> 6410387

Protein-primed initiation of phage phi 29 DNA replication.

K Watabe, M Shin, J Ito.   

Abstract

We recently reported the development of an in vitro replication system for bacteriophage phi 29 DNA. We have used this system for the isolation of replication activity associated with gene 3 protein (terminal protein) from phi 29-infected Bacillus subtilis cells. We utilized two assay systems: (i) DNA replication dependent on phi 29 DNA with the 5' end covalently linked to terminal protein (DNA-protein) and (ii) the formation of complex between the terminal protein and dAMP. The DNA-replication and the complex-forming activities were purified together through all steps. The complex of terminal protein and dAMP formed in the purified fraction was shown to serve as an effective primer for successive chain elongation in the presence of dNTPs by a pulse-chase experiment. The protein fraction purified from cells infected with a temperature-sensitive phi 29 mutant in gene 3 was thermolabile compared to the wild-type activity in the assay system for complex formation. This shows that the purified fraction having replication activity includes the gene 3 product of phi 29. Both the DNA replication and the complex formation activities are highly specific for phi 29 DNA-protein as template. The product analysis of elongated DNA revealed that the replication starts at both termini of the phi 29 genome. These results are consistent with the basic elements of the protein-priming model for the initiation of linear DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6410387      PMCID: PMC384014          DOI: 10.1073/pnas.80.14.4248

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Identification of a protein linked to the ends of adenovirus DNA.

Authors:  D M Rekosh; W C Russell; A J Bellet; A J Robinson
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

Review 2.  Adenovirus DNA: structure and function of a novel replicon.

Authors:  E L Winnacker
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

3.  Characterization of a protein covalently linked to the 5' termini of the DNA of Bacillus subtilis phage phi29.

Authors:  M Salas; R P Mellado; E Viñuela
Journal:  J Mol Biol       Date:  1978-02-25       Impact factor: 5.469

4.  Sugar and disease.

Authors:  J Yudkin
Journal:  Nature       Date:  1972-09-22       Impact factor: 49.962

5.  Nucleotide sequences at the termini of phi 29 DNA.

Authors:  H Yoshikawa; T Friedmann; J Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  The protein covalently linked to the 5' termini of the DNA of Bacillus subtilis phage phi 29 is involved in the initiation of DNA replication.

Authors:  R P Mellado; M A Peñalva; M R Inciarte; M Salas
Journal:  Virology       Date:  1980-07-15       Impact factor: 3.616

7.  Structure of replicating DNA molecules of Bacillus subtilis bacteriophage phi 29.

Authors:  M R Inciarte; M Salas; J M Sogo
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

8.  DNA replication of bacteriophage phi 29: characterization of the intermediates and location of the termini of replication.

Authors:  N E Harding; J Ito
Journal:  Virology       Date:  1980-07-30       Impact factor: 3.616

9.  Genetic analysis of bacteriophage phi 29 of Bacillus subtilis: integration and mapping of reference mutants of two collections.

Authors:  R P Mellado; F Moreno; E Viñuela; M Salas; B E Reilly; D L Anderson
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

10.  Protein p3 is linked to the DNA of phage phi 29 through a phosphoester bond between serine and 5'-dAMP.

Authors:  J M Hermoso; M Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  13 in total

1.  An essential arginine residue for initiation of protein-primed DNA replication.

Authors:  J C Hsieh; S K Yoo; J Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Mapping of the DNA linking tyrosine residue of the PRD1 terminal protein.

Authors:  S Y Shiue; J C Hsieh; J Ito
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

Review 3.  Yeast chromosome replication and segregation.

Authors:  C S Newlon
Journal:  Microbiol Rev       Date:  1988-12

4.  Effect of NH4+ ions on phi 29 DNA-protein p3 replication: formation of a complex between the terminal protein and the DNA polymerase.

Authors:  L Blanco; I Prieto; J Gutiérrez; A Bernad; J M Lázaro; J M Hermoso; M Salas
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Characterization of the DNA-protein complex at the termini of the bacteriophage PRD1 genome.

Authors:  D H Bamford; L Mindich
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

6.  A novel DNA polymerase induced by Bacillus subtilis phage phi 29.

Authors:  K Watabe; J Ito
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

7.  Replication of bacteriophage phi 29 DNA in vitro: the roles of terminal protein and DNA polymerase.

Authors:  K Watabe; M Leusch; J Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

8.  Mercury resistance is encoded by transferable giant linear plasmids in two chesapeake bay Streptomyces strains.

Authors:  J Ravel; H Schrempf; R T Hill
Journal:  Appl Environ Microbiol       Date:  1998-09       Impact factor: 4.792

9.  ATP is required for initiation of poliovirus RNA synthesis in vitro: demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein.

Authors:  C D Morrow; J Hocko; M Navab; A Dasgupta
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

10.  Replication of phage phi 29 DNA with purified terminal protein and DNA polymerase: synthesis of full-length phi 29 DNA.

Authors:  L Blanco; M Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.